Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Modern Diagnostic & Research Centre ROE %?
Modern Diagnostic & Research CentreBOM:544673 15 ROE % is 10.51% as of Mar. 2026, which is 69% below its 10-year median of 34.36. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review. Among 197 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks better than 65.99% on this metric.
BOM:544673's ROE % is ranked better than 65.99% of 197
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.07
vs BOM:544673: 5.25
Modern Diagnostic & Research Centre (BOM:544673) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Modern Diagnostic & Research Centre ROE % Related Terms
Modern Diagnostic & Research Centre ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre ROE % Chart
Modern Diagnostic & Research Centre Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
ROE %
-96.12
65.40
55.46
13.25
Modern Diagnostic & Research Centre Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
ROE %
0.00
0.00
0.00
10.51
BOM:544673 vs TMO, DHR, IDXX: ROE % Comparison
For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Diagnostic & Research Centre ROE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's ROE % distribution charts can be found below:
* The bar in red indicates where Modern Diagnostic & Research Centre's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Modern Diagnostic & Research Centre (BOM:544673) has a ROE % of 10.51% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Modern Diagnostic & Research Centre and its competitors. This is 69% below median its historical median of 34.36. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #67 out of 197 companies in the Medical Diagnostics & Research industry, placing it in the top 34%.
Is Modern Diagnostic & Research Centre's ROE % too high?
Modern Diagnostic & Research Centre's current ROE % of 10.51% is 69% below median its 10-year median of 34.36. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #67 out of 197 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's ROE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #67 out of 197 companies for ROE %. This puts Modern Diagnostic & Research Centre in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Diagnostics & Research company?
A good ROE % depends on the Medical Diagnostics & Research industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Modern Diagnostic & Research Centre and its competitors. Modern Diagnostic & Research Centre's current ROE % is 10.51%, which is 69% below median its own 10-year median of 34.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current ROE % of 10.51%. The current ROE % is 10.51%, which is 69% below median its 10-year median of 34.36. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current ROE % is 10.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score
Get the complete analysis for BOM:544673
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544673 has been successfully added to your 
